BID Back

BH3 interacting domain death agonist

External References:      Wikipedia GeneCards HUGO COSMIC Google Scholar

NCBI Description of BID
This gene encodes a death agonist that heterodimerizes with either agonist BAX or antagonist BCL2. The encoded protein is a member of the BCL-2 family of cell death regulators. It is a mediator of mitochondrial damage induced by caspase-8 (CASP8); CASP8 cleaves this encoded protein, and the COOH-terminal part translocates to mitochondria where it triggers cytochrome c release. Multiple alternatively spliced transcript variants have been found, but the full-length nature of some variants has not been defined.

Community Annotation of BID Add / Edit BID: Annotations

No community annotations yet for BID.
Sort mutations by: Tumor type  Mutation type  Position  
Straightedge cursor Expand

Figure notes


• "Mouse over" a mutation to see details.
• Missense green saturation indicates evolutionary conservation of the mutated positions.
• Red hashes in protein strip are splice sites.
• Blue-white-red bars are log2 copy ratio distributions (–1 to +1) from Zack et al. (2013).


Legend

BID is highly significantly mutated in
(none)
BID is significantly mutated in
(none)
BID is near significance in
(none)

Click on a tumor type to see its full list of significant genes.

Data details


• Mutation list for BID